Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
2010
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
2012
Potential for therapeutic manipulation of the UPR in disease
2013
Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity
2010
HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma
2015
CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells
2015
The molecular hallmarks of epigenetic control
2016 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Proteasome inhibitors in cancer therapy
2017
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
2015
Lenalidomide downregulates the cell survival factor, interferon regulatory factor‐4, providing a potential mechanistic link for predicting response
2011
Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
2010
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
2012
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Regulation and Functions of the ER-Associated Nrf1 Transcription Factor
2022 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma
2016
A Peroxidase Gene Promoter Induced by Phytopathogens and Methyl Jasmonate in Transgenic Plants
1997
A Large Family of Class III Plant Peroxidases
2001
Marine natural products
1990 Standout
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
2018
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Treatment of Obesity with Celastrol
2015 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
2014
A Perspective on Dietary Phytochemicals and Cancer Chemoprevention: Oxidative Stress, Nrf2, and Epigenomics
2012
Ookinete-induced midgut peroxidases detonate the time bomb in anopheline mosquitoes
2005
Epigenetic control of gene expression: Potential implications for cancer treatment
2017
Compliance to Oseltamivir among Two Populations in Oxfordshire, United Kingdom Affected by Influenza A(H1N1)pdm09, November 2009 – A Waste Water Epidemiology Study
2013
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
2008 Standout
New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings
2008
On becoming a parasite: evaluating the role of wall oxidases in parasitic plant development
1998
Causes and consequences of microRNA dysregulation in cancer
2009 Standout
Epigenetic protein families: a new frontier for drug discovery
2012
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
2021
PML targeting eradicates quiescent leukaemia-initiating cells
2008 Nature
Getting to the stem of chronic myeloid leukaemia
2008
The cancer stem cell: premises, promises and challenges
2011 Standout
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
DNA methylation-based biomarkers and the epigenetic clock theory of ageing
2018 Standout
Fz2 and Cdc42 Mediate Melanization and Actin Polymerization but Are Dispensable for Plasmodium Killing in the Mosquito Midgut
2006 StandoutNobel
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
2013 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
The molecular landscape of head and neck cancer
2018 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Driving CAR T-cells forward
2016
Postallograft lenalidomide induces strong NK cell–mediated antimyeloma activity and risk for T cell–mediated GvHD: Results from a phase I/II dose-finding study
2012
Reactive oxygen gene network of plants
2004 Standout
Non-specific low back pain
2011 Standout
Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma
2010
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
2018
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
2014
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Defense enzymes induced in cucumber roots by treatment with plant growth-promoting rhizobacteria (PGPR) and Pythium aphanidermatum
2000
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Targeted CML therapy: controlling drug resistance, seeking cure
2005
Epigenetics in pain and analgesia: An imminent research field
2010
Regulatory T Cells and Human Disease
2020 StandoutNobel
Peptidic degron for IMiD-induced degradation of heterologous proteins
2019 StandoutNobel
New and emerging HDAC inhibitors for cancer treatment
2014
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
2012
THE ROLE OF ROOT EXUDATES IN RHIZOSPHERE INTERACTIONS WITH PLANTS AND OTHER ORGANISMS
2006 Standout
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
2015
Resistance to proteasome inhibitors and other targeted therapies in myeloma
2018
Efficacy of Selected Natural Products as Therapeutic Agents against Cancer
2008
Use of Plant Growth-Promoting Bacteria for Biocontrol of Plant Diseases: Principles, Mechanisms of Action, and Future Prospects
2005 Standout
Rational Combinations Using HDAC Inhibitors
2009
Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
2012 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
2014 Standout
A Gateway Cloning Vector Set for High-Throughput Functional Analysis of Genes in Planta
2003 Standout
High expression of cereblon (CRBN ) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone
2013
DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
2017
The system of care for the diabetic foot: objectives, outcomes, and opportunities
2013
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
2011
Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific Mortality
2017
Multiple Myeloma
2011 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
2010
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of Simon J. Harrison being referenced
Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma
2016
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
2021
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma
2014
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopenia
2011
Targeting the silent minority: emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia
2004
Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate
2005
Differential Expression of Peroxidase Isogenes During the Early Stages of Infection of the Tropical Forage LegumeStylosanthes humilisbyColletotrichum gloeosporioides
1995
Do patients with diabetes wear shoes of the correct size?
2007
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1
2011
Predicting durable remissions following thalidomide therapy for relapsed myeloma
2009
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
2009
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen
2010
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
2010
Safety and Efficacy of the Combination of Bortezomib with the Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Trial.
2007
Novel AKT Inhibitor GSK2110183 Shows Favorable Safety, Pharmacokinetics, and Clinical Activity in Multiple Myeloma. Preliminary Results From a Phase I First-Time-In-Human Study
2011
Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
2012
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy
2010
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
2014
Regulatory T Cells (Treg) Are Depressed in Patients with Relapsed/Refractory Multiple Myeloma (MM) and Increases towards Normal Range in Responding Patients Treated with Lenalidomide (LEN).
2008
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
2017
Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy
2013
A phase 1 clinical trial evaluating marizomib, pomalidomide and low‐dose dexamethasone in relapsed and refractory multiple myeloma (NPI ‐0052‐107): final study results
2017
Global Measures of Peripheral Blood-Derived DNA Methylation as a Risk Factor in the Development of Mature B-Cell Neoplasms
2015
Clinical Studies of Histone Deacetylase Inhibitors
2009
Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England
2009